How to Use Metronidazole Vaginal Cream 1.3%
For bacterial vaginosis treatment, apply one full applicator (approximately 5 grams) of metronidazole vaginal cream 1.3% intravaginally once daily at bedtime for 5 days. 1
Application Instructions
- Wash hands thoroughly before and after application
- Remove the cap from the tube
- Screw the applicator onto the tube
- Squeeze the tube from the bottom to fill the applicator with the cream
- Unscrew the applicator from the tube
- While lying on your back with knees bent, gently insert the applicator into the vagina as far as it comfortably goes
- Push the plunger to release the medication
- Remove and discard the applicator after use
Important Treatment Considerations
- Timing: Apply at bedtime for best results 1
- Duration: Complete the full 5-day course even if symptoms improve 2
- Sexual activity: Abstain from sexual intercourse until completing the full treatment course to ensure effectiveness and minimize reinfection risk 2
- Alcohol restriction: Avoid alcohol during treatment and for 24 hours afterward to prevent disulfiram-like reactions (nausea, vomiting, flushing) 2
Efficacy and Alternatives
Metronidazole vaginal formulations are highly effective for bacterial vaginosis treatment, with cure rates of approximately 75-92.5% 3. This is comparable to oral metronidazole (84-90% cure rate) but with significantly fewer side effects 3.
Alternative treatments include:
- Oral metronidazole 500 mg twice daily for 7 days (95% cure rate) 2
- Clindamycin cream 2% intravaginally at bedtime for 7 days (comparable efficacy) 2
Common Side Effects and Precautions
- Local irritation or discomfort
- Vaginal candidiasis may develop after treatment (occurs in approximately 8-15% of patients) 4
- Less systemic side effects compared to oral metronidazole 3
- Significantly lower rates of nausea (10.2% vs 30.4%), abdominal pain (16.8% vs 31.9%), and metallic taste (8.8% vs 17.9%) compared to oral treatment 3
Follow-up Recommendations
- Follow-up visits are not necessary if symptoms resolve 2
- If symptoms persist or recur, consult your healthcare provider
- Pregnant women should have follow-up evaluation 1 month after treatment completion 2